Malocclusion, Dental crowding.. Anomalies of dental relationship
Conditions
Interventions
Intervention 1: Intervention group: 25 participants, the medication (400 mg Ibuprofen (Advil? Pfizer Inc.)) will be given to the first groups thirty minutes before the TAD placement. Intervention 2: C
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
13 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients treated with fixed orthodontic appliances Patients that only need one TAD in the posterior part of the maxilla Patients that will agree to participate in the clinical trial
Exclusion criteria
Exclusion criteria: Patients with poor oral hygiene or severe gingivitis Patients with systemic diseases Patients who currently are using other pain killer medications Patients who are allergic to any of TAD, Ibuprofen, or Placebo medication Patients who can not swallow
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity and type of pain during different times. Timepoint: severity and type of pain will be recorded at the following times: immediately after TAD placement (T1), 1 hour after TAD placement (T2), 12 hours after TAD placement (T3), 24 hour after TAD placement (T4). Method of measurement: The patients will be asked to fill a questionnaire form, this form is consisted of a Persian translated copy of short form of McGill Pain questionnaire (SF-MPQ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArman Mohammadi Shayan
Tabriz University of Medical Sciences
Outcome results
None listed